A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
By the time a 45-year-old patient with hypertension, slurred speech, and weakness in the right arm and right leg was examined in the emergency department, his symptoms had completely disappeared. However, examination, labs, and imaging showed the case was anything but "resolved."
Which sports-related migraine is associated with longer recovery time, as well as cognitive, neurobehavioral, and somatic symptoms? Test your skills in this quiz.
The aim of a randomized controlled trial was to see if aerobic and strength training can successfully slow cognitive decline. The results might surprise you.
Nearly a decade in the making, revised guidelines provide 8 key points for effective nonpharmacologic treatment of epilepsy in childhood.
From documentaries to dramas, these movies expose the hidden disability of epilepsy through film and shed light on the topic, potentially helping patients better understand their illness.
Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.
New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.